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Abstract
 
Mast cells were depleted in the peritoneal cavity of WBB6F
 
1
 
-
 
tg/tg
 
 mice that did not express a
 
transcription factor, MITF. When acute bacterial peritonitis was induced in WBB6F
 
1
 
-
 
 
 
/
 
 
 
,
 
WBB6F
 
1
 
-
 
W/W
 
v
 
, and WBB6F
 
1
 
-
 
tg/tg
 
 mice, the proportion of surviving WBB6F
 
1
 
-
 
 
 
/
 
 
 
 mice
was significantly higher than that of surviving WBB6F
 
1
 
-
 
W/W
 
v
 
 or WBB6F
 
1
 
-
 
tg/tg
 
 mice. The
poor survival of WBB6F
 
1
 
-
 
W/W
 
v
 
 and WBB6F
 
1
 
-
 
tg/tg
 
 mice was attributed to the deficient in-
flux of neutrophils into the peritoneal cavity. The injection of cultured mast cells (CMCs) de-
rived from WBB6F
 
1
 
-
 
 
 
/
 
 
 
 mice normalized the neutrophil influx and reduced survival rate in
WBB6F
 
1
 
-
 
W/W
 
v
 
 mice, but not in WBB6F
 
1
 
-
 
tg/tg
 
 mice. This was not attributable to a defect
of neutrophils because injection of TNF-
 
 
 
 increased the neutrophil influx and survival rate in
both WBB6F
 
1
 
-
 
W/W
 
v
 
 and WBB6F
 
1
 
-
 
tg/tg
 
 mice. Although WBB6F
 
1
 
-
 
 
 
/
 
 
 
 CMCs injection
normalized the number of mast cells in both the peritoneal cavity and mesentery of WBB6F
 
1
 
-
 
W/W
 
v
 
 mice, it normalized the number of mast cells only in the peritoneal cavity of
WBB6F
 
1
 
-
 
tg/tg
 
 mice. Mast cells within the mesentery or mast cells in the vicinity of blood
vessels appeared to play an important role against the acute bacterial peritonitis. WBB6F
 
1
 
-
 
tg/tg
 
mice may be useful for studying the effect of anatomical distribution of mast cells on their
antiseptic function.
Key words: mast cell • innate immunity • MITF • acute bacterial peritonitis • TNF-
 
 
 
Introduction
 
The mouse 
 
mi
 
 locus encodes a transcription factor belong-
ing to the basic-helix-loop-helix-leucine zipper family
 
(hereafter, microphthalmia transcription factor [MITF]
 
*
 
)
(1, 2). The mutant 
 
mi
 
 allele produces an abnormal MITF,
in which 1 out of 4 consecutive arginines is deleted in the
basic domain (hereafter, 
 
mi-
 
MITF) (1, 3, 4). The 
 
mi
 
-MITF
is defective in DNA binding, nuclear translocation and
transactivation of target genes (5–13). On the other hand,
the mutant 
 
tg
 
 allele is a transgene insertion mutation in the
5
 
 
 
 flanking region of the MITF gene (1, 14). Although the
coding region of the MITF gene was normal in C57BL/6
(B6)-
 
tg/tg
 
 mice, no significant amount of MITF was de-
tected in cultured mast cells (CMCs) derived from the
spleen of B6-
 
tg/tg
 
 mice (15).
Both B6-
 
mi/mi
 
 and B6-
 
tg/tg
 
 mice show microphthalmia,
lack of melanocytes, and decrease of skin mast cells (16).
B6-
 
mi/mi
 
 mice show osteopetrosis, but B6-
 
tg/tg
 
 mice do
not (17). Most B6-
 
mi/mi
 
 mice die on weaning due to the
failure of teeth eruption caused by the osteopetrosis,
whereas most B6-
 
tg/tg
 
 mice survived to adulthood. The
number of mast cells in skin tissues was comparable between
B6-
 
mi/mi
 
 and B6-
 
tg/tg
 
 mice (one third that of B6-
 
 
 
/
 
 
 
mice; reference 18). However, the decrease of heparin
content in skin mast cells was observed only in B6-
 
mi/mi
 
mice (19).
Although mast cells develop before birth in the skin tis-
sue of normal B6-
 
 
 
/
 
 
 
 mice, they develop after weaning
in tissues other than the skin of B6-
 
 
 
/
 
 
 
 mice (20). As
adult B6-
 
tg/tg
 
 mice were easily obtained, we attempted to
investigate development of mast cells in tissues other than
the skin of B6-
 
tg/tg
 
 mice. We found the lack of mast cells
in the peritoneal cavity of adult B6-
 
tg/tg
 
 mice.
Involvement of mast cells in the innate immunity has
 
been studied using WBB6F
 
1
 
-
 
W/W
 
v
 
 mice (21, 22). When
acute bacterial peritonitis was induced, the proportion of
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 B6, C57BL/6; CLP, caecal ligation and
puncture; CMC, cultured mast cell; MITF, microphthalmia transcription
factor; SCF, stem cell factor.T
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Partially Mast Cell–deficient 
 
tg/tg
 
 Mice
 
surviving WBB6F
 
1
 
-
 
W/W
 
v
 
 mice was significantly lower
than that of WBB6F
 
1
 
-
 
 
 
/
 
 
 
 mice (21, 22). The prior in-
traperitoneal transplantation of CMCs derived from
WBB6F
 
1
 
-
 
 
 
/
 
 
 
 mice normalized the reduced proportion
of surviving WBB6F
 
1
 
-
 
W/W
 
v
 
 mice (21, 22). In the present
study, we examined whether comparable results were ob-
tained in WBB6F
 
1
 
-
 
tg/tg
 
 mice, which lacked peritoneal
mast cells as WBB6F
 
1
 
-
 
W/W
 
v
 
 mice. Although the propor-
tion of surviving WBB6F
 
1
 
-
 
tg/tg
 
 mice was reduced as
WBB6F
 
1
 
-
 
W/W
 
v
 
 mice, the reduced survival rate was not
normalized by the prior transplantation of WBB6F
 
1
 
-
 
 
 
/
 
 
 
CMCs. We investigated the mechanism of this unexpected
result and found that the anatomical distribution of the
transplanted CMCs was different between WBB6F
 
1
 
-
 
tg/tg
 
and WBB6F
 
1
 
-
 
W/W
 
v
 
 mice.
 
Materials and Methods
 
Mice.
 
The original stock of B6-
 
Miwh/  mice was purchased
from The Jackson Laboratory. The B6-miew/  and B6-mice/ 
mice were given by Dr. M.L. Lamoreux (Texas A&M Univer-
sity, College Station, TX). The original stock of VGA-9-tg/tg
mice, in which the mouse vasopressin-Escherichia coli  -galactosi-
dase transgene was integrated at the 5  flanking region of the
MITF gene (1), was given by H. Arnheiter (National Institutes of
Health, Bethesda, MD). B6-Miwh/ , B6-miew/ , and B6-mice/ 
mice were maintained by consecutive backcrosses to our own in-
bred B6 colony (more than 18 generations at the time of the
present experiment). Homozygous mice were produced by
crosses between female and male heterozygotes of each genotype,
and selected by their white coat color. The VGA-9-tg/tg mice
were maintained by repeated backcrosses to our own inbred B6
and WB colonies more than 12 generations. B6-tg/  mice were
crossed together, and WB-tg/  mice were crossed to B6-tg/ 
mice. The resulting B6-tg/tg and WBB6F1-tg/tg mice were se-
lected by their white coat color. WBB6F1- W/Wv and WBB6F1-
 /  mice were purchased from the Japan SLC.
Estimation of Mast Cell Numbers in the Peritoneal Cavity and Tis-
sues. To harvest peritoneal cells, 2 ml of Tyrode’s buffer (23)
containing 0.1% gelatin (Sigma-Aldrich) was injected into the
peritoneal cavity, and the abdomen was massaged gently for 30 s.
The peritoneal cavity was carefully opened, and the fluid contain-
ing peritoneal cells was aspirated with a Pasteur pipette. After cen-
trifugation, the pellet was resuspended with the Tyrode’s buffer
(1.0 ml), and was divided into two parts. One part (0.8 ml) was
used for the direct counting of mast cells as described by Gilbert
and Ornstein (24). The cell suspension was centrifuged again, sus-
pended in the Tyrode’s buffer (0.1 ml), and diluted with 0.4 ml
saline containing 0.1% EDTA-Na (solution A). Then 0.45 ml of a
solution containing 0.076% cetylpyridinium chloride, 0.7% lan-
thanum chloride-6H2O, 0.9% NaCl, 0.21% Tween 20 (Sigma-
Aldrich), and 0.143% alcian blue 8GX (Eastman Kodak Co.; solu-
tion B) were added to the cell suspension. After 1 min of gentle
agitation, 0.05 ml of 1 N HCl (solution C) was added, and the
mixture was gently agitated. The cell suspension was centrifuged,
resuspended in 0.05 ml of the mixture of the Tyrode’s buffer and
solutions A, B, and C (Tyrode:A:B:C   2:8:9:1). After 20 min,
alcian blue–positive cells were counted with a standard hemocy-
tometer. Numbers of mast cells per mouse were calculated.
Another part (0.2 ml) of the peritoneal cell suspension was
centrifuged at 600 rpm for 5 min with a Cytospin 2 centrifuge
(Shandon) to attach cells to a microscope slide. The cytospin
preparations were fixed in Carnoy’s solution, and stained with al-
cian blue and nuclear fast red. Proportion of alcian blue-positive
cells in 1,000 nucleated peritoneal cells was determined.
Mast cell numbers in the mesentery, glandular stomach, spleen,
and lung were estimated as described previously (18, 20, 25).
CMCs. PWM-stimulated spleen cell–conditioned medium
(PWM-SCM) was prepared according to the method described
by Nakahata et al. (26). Mice of B6- / , B6-tg/tg, and
WBB6F1- /  were used to obtain CMCs. Mice were killed
by decapitation after ether anesthesia, and spleens were re-
moved. Spleen cells were cultured in  -MEM (ICN Biomedi-
cals) supplemented with 10% PWM-SCM and 10% FCS (Nip-
pon Bio-supp Center). Half of the medium was replaced every
7 d. More than 95% of cells were CMCs 4 wk after the initia-
tion of the culture.
Intraperitoneal Injection of CMCs. CMCs (1.0   106) derived
from B6- / , B6-tg/tg, or WBB6F1- /  mice were suspended
in 0.5 ml of  -MEM, and were injected into the peritoneal cavity
of the recipient mice. At the intervals indicated, peritoneal cells
were harvested as described above. Proportions of mast cells in
1,000 peritoneal cells were determined as mentioned above.
Caecal Ligation and Puncture. Caecal ligation and puncture
(CLP) was performed as described previously by Echtenacher et
al. (21) with slight modifications. In brief, the mice were anesthe-
tized by sevofrane (Maruishi Pharmaceuticals). A 1-cm midline
incision on the anterior abdominal wall was made. The cecum
was exposed and filled with feces by squeezing stool back from
the ascending colon. The cecum was 50% ligated below the ileo-
cecal valve and then punctured using a 0.65 mm needle followed
by gentle squeezing of the cecum. Mice were examined every
day for survival rate.
Neutrophil Counts in Peritoneal Exudates. Peritoneal exudates
were collected from mice and total cell numbers were counted.
The cytospin preparation of peritoneal cells was made as de-
scribed previously. The cells were stained with May-Grunwald-
Giemsa. Proportions of neutrophils in peritoneal cells were deter-
mined. Then the number of neutrophils was calculated.
Injection of TNF- . Acute bacterial peritonitis was induced
by CLP in WBB6F1-tg/tg and WBB6F1-W/Wv mice. Immedi-
ately after CLP, a single intraperitoneal injection of murine TNF- 
(PeproTech; reference 21) or control diluents (0.5 ml PBS per
mouse) was done. Numbers of neutrophils were counted 3 h af-
ter CLP. Survival rate was also determined.
Intravenous Injection. CMCs (1.0   106) derived from
WBB6F1- /  mice were suspended in 0.2 ml of  -MEM, and
were injected into the tail vein of the recipient mice. Proportions
of mast cells in 1,000 peritoneal cells and number of mast cells in
the mesentery, glandular stomach, and spleen were determined 5
wk after the injection.
Mast Cell Staining with Berberine Sulfate. The cytospin prepa-
ration of peritoneal cells was made as described previously. After
fixation with Carnoy’s fluid, the cells were stained with berberine
sulfate (Sigma-Aldrich), as described by Enerback (27).
Semiquantitative RT-PCR Analysis. 4  g of total RNAs were
extracted from the mesentery and spleen of WBB6F1- / ,
WBB6F1-W/Wv, and WBB6F1-tg/tg mice. The extracted RNAs
were subjected to reverse transcription by Superscript (Invitrogen
Corp.), and the single strand cDNAs were obtained. 1, 0.1, or
0.01  l of the reaction mixture was added to 25  l of PCR mix-
ture containing 1.25 U of Taq DNA polymerase (Roche Diag-
nostics GmbH) and 25 pmol of each of the primers. PCR was
performed to amplify the fragment of the MITF, stem cell factorT
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(SCF), and  -actin genes using the following primers; 5 -ACA-
GAGTCTGAAGCAAGAGCA and 5 -GGTGATGGTACCG-
TCCGTGAG for MITF, 5 -AAGACTCGGGCCTACAATG-
GACAGCCATGG and 5 -CAATGTTGATACGTCCACAA-
TTAC for SCF, and 5 -TAAAGACCTCTATGCCAACAC and
5 -CTCCTGCTTGCTGATCCACAT for  -actin.
Statistical Analysis. Statistical analysis of most data was per-
formed using the Student’s t test. Statistical analysis of the survival
rate was done using the log rank test.
Results
Mast Cell Deficiency of tg/tg Mice. The number of mast
cells was examined at various ages in the peritoneal cavity
and glandular stomach of B6- /  and B6-tg/tg mice. In
B6- /  mice, mast cells appeared in the peritoneal cavity
6 wk after birth and in the glandular stomach 4 wk after
birth (Fig. 1). The number of mast cells increased thereaf-
ter. On the other hand, in B6-tg/tg mice, no detectable
number of mast cells appeared in either peritoneal cavity or
glandular stomach at any ages examined (Fig. 1). We also
examined whether mast cells appeared in spleens and lungs
of B6-tg/tg mice at 10 wk of age. Mast cells were not de-
tectable in histological sections of lungs and spleens of B6-
tg/tg mice (unpublished data).
We further investigated the mast cell deficiency in the
peritoneal cavity of other MITF mutants. The number of
peritoneal mast cells shown in Fig. 1 was obtained by the
direct counting of peritoneal cells with the hemocytome-
ter. In addition to the direct counting, another method
was used to identify mast cells more precisely. Cytospin
preparations of peritoneal cell suspensions were made, and
proportions of mast cells in 1,000 nucleated peritoneal cells
were counted. A few mast cells were recognized in the
cytospin preparations of peritoneal cells obtained from B6-
tg/tg, B6-miew/miew, B6-mice/mice, and B6-Miwh/Miwh
mice, but the mean number of mast cells did not exceed
0.1 per 1,000 nucleated peritoneal cells in each mutant
mouse (Table I). The results obtained by these two meth-
ods were consistent and showed the apparent deficiency of
mast cells in the peritoneal cavity of B6-miew/miew, B6-mice/
mice, and B6-Miwh/Miwh mice as in the case of B6-tg/tg mice
(Table I).
We injected B6- /  or B6-tg/tg CMCs into the peri-
toneal cavity of B6-tg/tg mice. At various weeks after injec-
tion, we examined the proportions of mast cells in 1,000
nucleated peritoneal cells. The B6- /  CMCs survived 5
wk after the injection, but B6-tg/tg CMCs did not (Fig. 2).
We also used WBB6F1-W/Wv mice as recipients because
they are used as a standard of mast cell–deficient animals
(28, 29). B6-tg/tg CMCs did not survive in the peritoneal
cavity of WBB6F1-W/Wv mice, either (Fig. 2).
Mortality from Acute Bacterial Peritonitis. As mast cell de-
ficiency was observed in the peritoneal cavity of B6-tg/tg
mice, we induced the acute bacterial peritonitis by CLP
and compared the survival rate between B6-tg/tg and B6-
 /  mice. The proportion of surviving B6-tg/tg mice was
significantly lower than that of surviving B6- /  mice
Figure 1. The number of mast cells in the peritoneal cavity (A) and
glandular stomach (B) of B6- /  and B6-tg/tg mice. The number of
mast cells was examined at various times after birth. At each time point,
the mean values of 6 to 8 mice were plotted with bars indicating SE.
Table I. Mast Cell Deficiency in the Peritoneal Cavity of Various 
MITF Mutant Mice of B6 Strain Estimated by Two Methods
Direct count
Proportion in 
cytospin preparation
Micea
No. of
mice
No. of mast cells/
mouse (  103)b
No. of mast cells/
103 peritoneal cellsc
B6- /  8 20.0   2.5 29.5   2.8
B6-tg/tg 9N D d  0.1
B6-miew/miew 8N D d  0.1
B6-mice/mice 10 NDd  0.1
B6-Miwh/Miwh 8N D d  0.1
aThe number of mast cells was examined at 10 wk of age.
bAfter harvesting peritoneal cells, cells were divided into two parts.
One part was stained with alcian blue in suspension, and the positive
cells were counted with a hemocytometer. Mean and SE are shown.
cCytospin preparation was made from another part and was stained
with alcian blue and nuclear fast red. Proportion of alcian blue-positive
cells to 103 nucleated peritoneal cells was determined. Mean and SE
are shown.
dNot detectable.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
1420 Partially Mast Cell–deficient tg/tg Mice
(Fig. 3). Then we investigated the effect of the prior trans-
plantation of B6- /  CMCs because Echtenacher et al.
(21) reported that the reduced survival rate of WBB6F1-
W/Wv mice after CLP is normalized by the prior transplan-
tation of WBB6F1- /  CMCs. Unexpectedly, the prior
transplantation of B6- /  CMCs (2.0   106) did not in-
crease the survival rate of B6-tg/tg mice after CLP (Fig. 3).
There was a possibility that the difference of mouse ge-
netic background (B6 versus WBB6F1) may cause this un-
expected result. We produced WBB6F1-tg/tg mice, and in-
duced the acute bacterial peritonitis in intact WBB6F1-tg/tg
mice and WBB6F1-tg/tg mice which had received the prior
transplantation of WBB6F1- /  CMCs. As a control, we
also induced the bacterial peritonitis in intact WBB6F1-
W/Wv mice and WBB6F1-W/Wv mice which had re-
ceived the prior tansplantation of WBB6F1- /  CMCs.
WBB6F1-W/Wv mice gave a comparable result that had
been reported by Echtenacher et al. (21; Fig. 4 A). In con-
trast, the result obtained by WBB6F1-tg/tg mice was con-
sistent with the result of B6-tg/tg mice (compare Figs. 3
and 4 B).
The number of neutrophils was counted in the peri-
toneal cavity of WBB6F1- / , WBB6F1-W/Wv, and
WBB6F1-tg/tg mice 3 h after CLP. The number of neutro-
phils was significantly lower in the peritoneal cavity of
WBB6F1-W/Wv mice and WBB6F1-tg/tg mice than in the
peritoneal cavity of WBB6F1- /  mice (Fig. 5). The
prior transplantation of WBB6F1- /  CMCs normalized
the neutrophil response in WBB6F1-W/Wv mice but not
in WBB6F1-tg/tg mice (Fig. 5). Figure 2. Survival of transplanted CMCs in the peritoneal cavity of
B6-tg/tg and WBB6F1-W/Wv mice. B6- /  or B6-tg/tg CMCs (1.0  
106) were injected into the peritoneal cavity of the recipient mice. At 1,
3, or 5 wk after the injection, the proportion of mast cells in 1,000 nucle-
ated peritoneal cells was determined. The mean values of five mice were
shown with bars indicating SE. In some cases, SE was too small to be
shown by bars. *P   0.01 by t test when compared with the value ob-
tained after the injection of B6- /  CMCs.
Figure 3. Effect of  /  CMC injection on the survival of B6-tg/tg
mice. Peritonitis was induced by CLP in B6- /  mice, B6-tg/tg mice,
and B6-tg/tg mice which received the prior intraperitoneal injection of
B6- /  CMCs 5 wk before CLP. Number of mice is shown in paren-
theses. The proportion of survival was compared by log rank test.
Figure 4. Effect of injection of WBB6F1- /  CMCs on survival of
WBB6F1-W/Wv and WBB6F1-tg/tg mice. Peritonitis was induced by
CLP. (A) Proportions of surviving WBB6F1- /  mice, WBB6F1-W/Wv
mice, and WBB6F1-W/Wv mice that had received the prior intraperito-
neal injection of WBB6F1- /  CMCs 5 wk before CLP. (B) Propor-
tions of surviving WBB6F1- /  mice, WBB6F1-tg/tg mice, and
WBB6F1-tg/tg mice that had received the prior intraperitoneal injection
of WBB6F1- /  CMCs 5 wk before CLP. The number of mice is
shown in parentheses. The proportion of survival was compared by log
rank test.T
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1421 Jippo et al.
There was a possibility that the migration activity of
neutrophils of WBB6F1-tg/tg mice was defective. The ef-
fect of intraperitoneal injection of TNF-  on the num-
ber of infiltrating neutrophils was compared between
WBB6F1-W/Wv and WBB6F1-tg/tg mice. TNF-  was in-
jected intraperitoneally immediately after CLP. The num-
ber of infiltrating neutrophils after CLP was increased by
the intraperitoneal injection of TNF-   not only in
WBB6F1-W/Wv mice but also in WBB6F1-tg/tg mice
(Fig. 6). The values of both mice were comparable. The
survival rate was also increased by the injection of TNF- 
in both WBB6F1-W/Wv (Fig. 7 A) and WBB6F1-tg/tg
mice (Fig. 7 B).
Different Effect of CMC Transplantation between tg/tg and
W/Wv Mice. Presence of mast cells in the peritoneal cav-
ity of B6-tg/tg mice 5 wk after intraperitoneal transplanta-
tion of B6- /  CMCs was shown in Fig. 2.
The prior intraperitoneal transplantation of WBB6F1-
 /  CMCs normalized the neutrophil response and sur-
vival rate of WBB6F1-W/Wv mice, but did not affect the
neutrophil response and survival rate of WBB6F1-tg/tg
mice. There was a possibility that the intraperitoneal trans-
plantation of WBB6F1- /  CMCs had different effects
between WBB6F1-W/Wv and WBB6F1-tg/tg recipients.
We compared the effect of the intraperitoneal transplanta-
tion between WBB6F1-W/Wv and WBB6F1-tg/tg mice.
The number of mast cells in the peritoneal cavity was
comparable between WBB6F1-W/Wv and WBB6F1-tg/tg
mice (Table II). Although WBB6F1- /  CMCs were not
stained with berberine sulfate before the transplantation,
mast cells recovered from the peritoneal cavity of either
WBB6F1-W/Wv or WBB6F1-tg/tg mice were stained with
berberine sulfate (unpublished data), suggesting the con-
tent of heparin (27). The number of mast cells in the
stretch preparation of the mesentery of WBB6F1-W/Wv
mice was normalized by the intraperitoneal transplantation
of WBB6F1- /  CMCs (Table II and Fig. 8). However,
the same procedure did not result in development of mast
cells in the mesentery of WBB6F1-tg/tg mice (Table II and
Fig. 8).
Intraperitoneal transplantation of WBB6F1- /  CMCs
resulted in development of mast cells in the mesentery of
Figure 6. Effect of TNF-  in-
jection on the number of infil-
trating neutrophils in the perito-
neal cavity of WBB6F1-W/Wv
and WBB6F1-tg/tg mice. Mice
received TNF-  injection im-
mediately after CLP and the
number of neutrophils was
counted 3 h after CLP. Mean  
SE of 5 to 7 mice are shown.
*P   0.01 by t test when com-
pared with the value of control
mice of the same genotype.
Figure 5. Number of infiltrating neutrophils in the peritoneal cavity of
WBB6F1- /  mice, WBB6F1-W/Wv, mice, and WBB6F1-W/Wv mice
that had received the prior intraperitoneal injection of WBB6F1- / 
CMCs 5 wk before CLP, WBB6F1-tg/tg mice and WBB6F1-tg/tg mice
that had received the prior intraperitoneal injection of WBB6F1- / 
CMCs 5 wk before CLP. Numbers of mice are shown in parentheses. *P  
0.01 by t test, when compared with the value observed in WBB6F1- / 
mice.
Figure 7. Effect of TNF-  injection on the proportions of surviving
WBB6F1-W/Wv (A) and WBB6F1-tg/tg mice (B). The experimental
condition was same as the experiment shown in Fig. 6. Numbers of mice
are shown in parentheses. The proportion of survival was compared by
log rank test.T
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1422 Partially Mast Cell–deficient tg/tg Mice
WBB6F1-W/Wv mice but not in the mesentery of
WBB6F1-tg/tg mice. Next, WBB6F1- /  CMCs
were transplanted intravenously into WBB6F1-W/Wv and
WBB6F1-tg/tg mice. As already reported, mast cells ap-
peared in the peritoneal cavity, mesentery, stomach, and
spleen of WBB6F1-W/Wv mice (25), but did not in the
corresponding tissues of WBB6F1-tg/tg mice (Table III and
Fig. 8).
The deficient development of mast cells in the mesen-
tery was confirmed in B6-tg/tg mice after intraperitoneal
transplantation of B6- /  CMCs (Table IV). Since there
is a possibility that the transgene insertion in the tg allele af-
fects the mi gene as well as neighboring genes which may
function in the mesentery, we also transplanted B6- / 
CMCs into the peritoneal cavity of B6-miew/miew mice. Al-
though the phenotype of B6-miew/miew mice is not distin-
guishable from that of B6-tg/tg mice, the miew allele en-
codes mutant MITF with a large deletion of the basic
domain (30). In spite of the difference, the intraperitoneal
injection of B6- /  CMCs gave similar results in both
B6-tg/tg and B6-miew/miew mice. Mast cells appeared in the
peritoneal cavity but did not in the mesentery (Table IV).
There is a possibility that tissues of mice of tg/tg geno-
type have a defect in microenvironment that is necessary
for the migration and settlement of normal CMCs. First,
we examined whether MITF was expressed in the mesen-
tery and spleen of WBB6F1- / , WBB6F1-W/Wv, and
WBB6F1-tg/tg mice. The expression of MITF mRNA was
detectable in the mesentery and spleen of intact WBB6F1-
 /  and WBB6F1-W/Wv mice, but did not in those tis-
sues of intact WBB6F1-tg/tg mice (Fig. 9). As the defect of
WBB6F1-tg/tg mice was somewhat reminiscent of the de-
fect of WBB6F1-Sl/Sld mice that do not produce a ligand
of c-kit receptor tyrosine kinase (SCF; references 31–34),
we next examined the expression of SCF in the mesentery
and spleen of intact WBB6F1- / , WBB6F1-W/Wv, and
WBB6F1-tg/tg mice. In contrast to our expectation, the
amount of SCF mRNA was comparable among tissues of
all the WBB6F1- / , WBB6F1-W/Wv, and WBB6F1-tg/
tg mice (Fig. 9).
Discussion
Mast cells were practically absent in the peritoneal cavity
of B6-tg/tg, B6-miew/miew, B6-mice/mice, and B6-Miwh/Miwh
mice. Since mast cells develop in the peritoneal cavity 6 wk
after birth even in B6- /  mice and since most of B6-mi/
mi mice die on weaning (4 wk after birth), it is rather diffi-
Table II. Number of Mast Cells in the Peritoneal Cavity and 
Mesentery of WBB6F1-W/Wv and WBB6F1-tg/tg Mice 5 wk after 
Intraperitoneal Injection of 106 WBB6F1- /  CMCs
No. of mast cellsa
Miceb
Peritoneal cavity
(no./103 peritoneal cells)c
Mesentery
(no./mm2)d
F1- /  mice (8) 31.0   4.4 10.4   2.8
F1-W/Wv mice (8)  0.1 NDe
F1-W/Wv mice that
received F1- /  CMCs (8) 35.8   4.2 11.4   1.8
F1-tg/tg mice (11)  0.1 NDe
F1-tg/tg mice that
received F1- /  CMCs (8) 36.1   5.6 NDe
aMean and SE are shown.
bNumber of mice is shown in parentheses.
cCytospin preparation was made from harvested peritoneal cells and
was stained with alcian blue and nuclear fast red. Proportion of alcian
blue-positive cells to 103 nucleated peritoneal cells was determined.
dNumber of mast cells per mm2 of stretched mesentery.
eNot detectable.
Figure 8. Nonappearance of
mast cells in the mesentery and
spleen of a WBB6F1-tg/tg mouse
5 wk after intraperitoneal trans-
plantation of WBB6F1- / 
CMCs. The mesentery and
spleen of an intact WBB6F1- / 
mouse and those of a WBB6F1-
W/Wv mouse which had re-
ceived the intraperitoneal trans-
plantation of WBB6F1- / 
CMCs are also shown. Arrows in
the spleen section of the
WBB6F1- /  mouse show
mast cells. The number of mast
cells in the spleen of the
WBB6F1-W/Wv mouse was re-
markably larger than that observed
in the intact WBB6F1- / 
mouse. Mast cells were stained
with alcian blue and nuclear fast
red. Original magnification,
 200.T
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1423 Jippo et al.
cult to evaluate mast cell number in the peritoneal cavity of
B6-mi/mi mice. However, mast cells are probably absent in
the peritoneal cavity of B6-mi/mi mice as well, because all
examined phenotypes of B6-mi/mi mice were the most se-
vere among all MITF mutant mice (11, 17, 30, 35, 36).
The mi and Miwh mutant alleles encode MITFs with dele-
tion or alteration of a single amino acid at the basic domain
(4). The miew and mice mutant alleles encode MITFs with
large deletion in the basic and zipper domains, respectively
(4, 36). All tg, miew, and mice are null mutations, whereas the
mi is an inhibitory mutation (11, 30, 36). The Miwh showed
decreased but detectable transcription activities on some
genes and also significant inhibitory effects on transcription
of other genes (35, 37). In spite of different structural and
functional abnormalities of each mutant MITF, depletion
of peritoneal mast cells was common among all MITF ho-
mozygous mutants examined. Tissues other than the skin
of all MITF mutant mice also lacked mast cells. In contrast,
mast cells were present in the skin tissue of all MITF mu-
tants (30, 35–37). Probably, the skin is an exceptional tissue
for development of mast cells. In fact, mast cells develop
before birth only in the skin tissue (20). Depletion of mast
cells in the peritoneal cavity appeared suitable for investiga-
tion of the mechanisms of development of mast cells.
The peritoneal cavity is also suitable for examining the
involvement of mast cells in the innate immunity (21, 22).
The reduced survival rate of WBB6F1-W/Wv mice after
CLP was normalized by the intraperitoneal transplantation
of WBB6F1- /  CMCs. WBB6F1-tg/tg mice also lacked
peritoneal mast cells and showed the reduced survival rate
after CLP. In contrast to WBB6F1-W/Wv mice, however,
the survival rate of WBB6F1-tg/tg mice was not normalized
by the prior transplantation of WBB6F1- /  CMCs. We
examined the effect of the transplantation between
WBB6F1-W/Wv and WBB6F1-tg/tg mice, and found that
anatomical distribution of mast cells was different between
them. Mast cell number was normalized in the peritoneal
cavity of both WBB6F1-W/Wv and WBB6F1-tg/tg mice.
Table III. Number of Mast Cells 5 wk after Intravenous Injection of 
106 WBB6F1- /  CMCs
No. of mast cellsa
Donors Recipientsb
Peritoneal 
cavityc Mesenteryd Stomache Spleenf
F1- /  F1-W/Wv (9) 5.0   1.0 1.9   0.4 178   10 41   3
F1- /  F1-tg/tg (9)  0.1g NDh NDh NDh
aMean and SE are shown.
bNumber of recipients is shown in parentheses.
cCytospin preparation was made from harvested peritoneal cells and
was stained with alcian blue and nuclear fast red. Proportion of alcian
blue-positive cells to 103 nucleated peritoneal cells was determined.
dNumber of mast cells per mm2 of stretched mesentery.
eNumber of mast cells per cm of stomach section.
fNumber of mast cells per mm2 of spleen section.
gP   0.01 by t test when compared to the value of WBB6F1-W/Wv
mice which received WBB6F1- /  CMCs.
hNot detectable.
Table IV. Number of Mast Cells in the Peritoneal Cavity and 
Mesentery of B6-tg/tg and B6-miew/miew Mice 5 wk after 
Intraperitoneal Injection of 106 B6- /  CMCs
No. of mast cellsa
Miceb
Peritoneal cavity
(no./103 peritoneal cells)c
Mesentery
(no./mm2)d
B6- /  Mice (8)e 29.5   2.8 8.4   1.4
B6-tg/tg mice (9)e  0.1 NDf
B6-tg/tg mice that received
B6- /  CMCs (12)g 29.7   2.9 NDf
B6-miew/miew mice (8)e  0.1 NDf
B6-miew/miew mice that received
B6- /  CMCs (8) 30.5   2.8 NDf
aMean and SE are shown.
bNumber of mice is shown in parentheses.
cCytospin preparation was made from harvested peritoneal cells and
was stained with alcian blue and nuclear fast red. Proportion of alcian
blue-positive cells to 103 nucleated peritoneal cells was determined.
dNumber of mast cells per mm2 of stretched mesentery.
eData of the same mice are shown in Table I.
fNot detectable.
gData of the same mice are shown in Fig. 2.
Figure 9. Expression levels of MITF and SCF mRNAs in the mesen-
tery and spleen of intact WBB6F1- / , WBB6F1-W/Wv, and
WBB6F1-tg/tg mice. Semiquantitative RT-PCR was done to compare
the expression levels of MITF, SCF, and  -actin mRNAs. RNA ex-
tracted from the mesentery and spleen of intact WBB6F1- / ,
WBB6F1-W/Wv, and WBB6F1-tg/tg mice were subjected to RT-PCR.T
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1424 Partially Mast Cell–deficient tg/tg Mice
Mast cells did appear in the mesentery of WBB6F1-W/Wv
mice, but did not in the mesentery of WBB6F1-tg/tg mice.
Mast cells within tissues or mast cells in the vicinity of
blood vessels appeared to play an important role against the
acute bacterial peritonitis induced by CLP.
Intraperitoneally transplanted CMCs of WBB6F1- / 
mouse origin invaded from the peritoneal cavity to the me-
sentery of WBB6F1-W/Wv mice but did not invade to the
mesentery of WBB6F1-tg/tg mice. Intravenously trans-
planted WBB6F1- /  CMCs invaded and settled in tis-
sues of WBB6F1-W/Wv mice, but did not in tissues of
WBB6F1-tg/tg mice. There is a possibility that the tissues of
WBB6F1-tg/tg mice have a defect in microenvironment
that is necessary for the migration and settlement of normal
CMCs. MITF was expressed in the mesentery and spleen
of WBB6F1- /  and WBB6F1-W/Wv mice but did not
in those of WBB6F1-tg/tg mice. If MITF is involved in the
transcription of microenvironmental factor(s) that play sig-
nificant roles for the migration and settlement of normal
CMCs, the absence of MITF may result in such a microen-
vironmental defect in tissues of WBB6F1-tg/tg mice. We
expected the deficient expression of SCF in the mesentery
and spleen of WBB6F1-tg/tg mice, but the amount of SCF
mRNA was comparable among the tissues of WBB6F1- / ,
WBB6F1-W/Wv, and WBB6F1-tg/tg mice. The microen-
vironmental defect of WBB6F1-tg/tg mice might be attrib-
utable to the deficient transcription of factor(s) other than
SCF. Such factor(s) remain to be identified.
Taken together, WBB6F1-tg/tg mice appeared useful for
studying the effect of anatomical distribution of mast cells
on their antiseptic function.
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